Healthcare - Biotechnology - NASDAQ - IL
$ 1.73
-1.14 %
$ 63.7 M
Market Cap
-6.65
P/E
INCOME STATEMENT
0
REVENUE
-8.89 M
OPERATING INCOME
-8.89 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Entera Bio Ltd.
| Revenue | 0 |
| Cost Of Revenue | 56 K |
| Gross Profit | -56 K |
| Operating Expenses | 8.86 M |
| Operating Income | -8.89 M |
| Other Expenses | -2 K |
| Net Income | -8.89 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Revenue | 0 | 0.1 | 0.6 | 0.4 | 0.2 | 0.5 | 0 | 0 | 0 |
| GROSS PROFIT | |||||||||
| Cost Of Revenue | 56 K | 0.1 | 0.4 | 0.2 | 0.2 | 0 | 43 K | 35 K | 28 K |
| Gross Profit | 56 K | 33 K | 0.2 | 0.2 | 26 K | 0.5 | 43 K | 35 K | 28 K |
| OPERATING INCOME | |||||||||
| Operating Expenses | 8.9 | 13.1 | 12.4 | 11.3 | 11.5 | 11.4 | 11.3 | 5.4 | 3.7 |
| Selling, General and Administrative Expenses | 4.4 | 7.3 | 5.7 | 4.9 | 4.3 | 2.8 | 8.6 | 2.7 | 1.6 |
| Research and Development Expenses | 4.5 | 5.8 | 6.8 | 6.4 | 7.2 | 8.5 | 2.8 | 2.6 | 2.1 |
| Operating Income | (8.9) | (13.0) | (12.2) | (11.1) | (11.5) | (10.9) | 11.3 | (5.4) | (3.7) |
| PRE-TAX INCOME | |||||||||
| Interest Income Expense | 0 | 0 | 29 K | 28 K | 84 K | 0 | 0 | 0 | 0 |
| Total Other Income | 31 K | 0.1 | 29 K | 28 K | 0.7 | 0.6 | 0.1 | 4.2 | (0.6) |
| Pre-Tax Income | (8.9) | (12.9) | (12.2) | (10.0) | (10.8) | (10.3) | (11.2) | (1.2) | (4.3) |
| NET INCOME | |||||||||
| Tax Provision | 29 K | 0.1 | 59 K | 20 K | 84 K | 0.6 | (0.1) | 0 | 0 |
| Net Income | (8.9) | (13.1) | (12.2) | (10.0) | (10.9) | (10.3) | (11.2) | (1.2) | (4.3) |
| EPS | 0.31 | 0.45 | 0.47 | 0.54 | 0.9 | 1.3 | 1.31 | 0.14 | 0.36 |